| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | EGF_1 | 5.10e-07 | 255 | 92 | 10 | PS00022 | |
| Domain | EGF | 2.38e-06 | 235 | 92 | 9 | SM00181 | |
| Domain | EGF_3 | 2.38e-06 | 235 | 92 | 9 | PS50026 | |
| Domain | EGF-like_dom | 3.82e-06 | 249 | 92 | 9 | IPR000742 | |
| Domain | EGF-like_CS | 5.60e-06 | 261 | 92 | 9 | IPR013032 | |
| Domain | EGF_2 | 6.33e-06 | 265 | 92 | 9 | PS01186 | |
| Domain | - | 6.36e-06 | 8 | 92 | 3 | 3.90.290.10 | |
| Domain | TB_dom | 9.51e-06 | 9 | 92 | 3 | IPR017878 | |
| Domain | TB | 9.51e-06 | 9 | 92 | 3 | PS51364 | |
| Domain | EGF-like_Ca-bd_dom | 3.39e-05 | 124 | 92 | 6 | IPR001881 | |
| Domain | EGF | 3.71e-05 | 126 | 92 | 6 | PF00008 | |
| Domain | EGF_CA | 1.29e-04 | 99 | 92 | 5 | PS01187 | |
| Domain | cEGF | 2.77e-04 | 26 | 92 | 3 | PF12662 | |
| Domain | cEGF | 2.77e-04 | 26 | 92 | 3 | IPR026823 | |
| Domain | EGF_CA | 3.42e-04 | 122 | 92 | 5 | SM00179 | |
| Domain | TB | 4.96e-04 | 7 | 92 | 2 | PF00683 | |
| Domain | zf-TRAF | 6.59e-04 | 8 | 92 | 2 | PF02176 | |
| Domain | EGF_CA | 8.60e-04 | 86 | 92 | 4 | PF07645 | |
| Domain | Growth_fac_rcpt_ | 1.05e-03 | 156 | 92 | 5 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 1.35e-03 | 97 | 92 | 4 | IPR018097 | |
| Domain | ASX_HYDROXYL | 1.51e-03 | 100 | 92 | 4 | PS00010 | |
| Domain | Znf_TRAF | 1.53e-03 | 12 | 92 | 2 | IPR001293 | |
| Domain | ZF_TRAF | 1.81e-03 | 13 | 92 | 2 | PS50145 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.87e-03 | 106 | 92 | 4 | IPR000152 | |
| Domain | - | 2.10e-03 | 14 | 92 | 2 | 3.90.890.10 | |
| Domain | SIAH-type | 2.75e-03 | 16 | 92 | 2 | IPR013323 | |
| Domain | Integrin_alpha-2 | 3.49e-03 | 18 | 92 | 2 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 3.49e-03 | 18 | 92 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 3.49e-03 | 18 | 92 | 2 | PF08441 | |
| Domain | Integrin_alpha | 3.49e-03 | 18 | 92 | 2 | IPR000413 | |
| Domain | Int_alpha | 3.89e-03 | 19 | 92 | 2 | SM00191 | |
| Domain | Int_alpha_beta-p | 3.89e-03 | 19 | 92 | 2 | IPR013519 | |
| Domain | BRCT | 3.89e-03 | 19 | 92 | 2 | PF00533 | |
| Domain | Ank_2 | 4.22e-03 | 215 | 92 | 5 | PF12796 | |
| Domain | DAPIN | 5.20e-03 | 22 | 92 | 2 | PS50824 | |
| Domain | FG_GAP | 5.20e-03 | 22 | 92 | 2 | PS51470 | |
| Domain | PYRIN | 5.20e-03 | 22 | 92 | 2 | SM01289 | |
| Domain | PYRIN | 5.20e-03 | 22 | 92 | 2 | PF02758 | |
| Domain | DAPIN | 5.20e-03 | 22 | 92 | 2 | IPR004020 | |
| Domain | BRCT | 5.20e-03 | 22 | 92 | 2 | SM00292 | |
| Domain | Ank | 5.40e-03 | 228 | 92 | 5 | PF00023 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.80e-05 | 39 | 69 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.16e-05 | 44 | 69 | 4 | M26969 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 MST1R TRAF4 TRIO PI4KA POLE OSBPL5 SHC1 LRP5 DDX56 HMGXB3 LTBP3 FBXL19 ITGA5 PUM1 ESPL1 ULK2 TTC38 PLEKHH3 | 1.12e-10 | 1105 | 94 | 19 | 35748872 |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23415911 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22028811 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8088805 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22106410 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18401429 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 17158237 | ||
| Pubmed | Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits. | 7.23e-06 | 2 | 94 | 2 | 25190493 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 32561545 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH7 NCAPG GTF3C1 PI4KA POLE UQCRFS1 NOL9 PUM1 STAG2 NOTCH3 NUP205 | 2.05e-05 | 857 | 94 | 11 | 25609649 |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23328522 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30595481 | ||
| Pubmed | Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). | 2.16e-05 | 3 | 94 | 2 | 7730318 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 25955828 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28673544 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 36122208 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22914734 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18672106 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 10743502 | ||
| Pubmed | 2.84e-05 | 22 | 94 | 3 | 35245678 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CYP26B1 GTF3C1 MCPH1 PI4KA KIF21A PIWIL2 ARHGEF17 ATXN1L DNAH14 NUP205 | 3.10e-05 | 736 | 94 | 10 | 29676528 |
| Pubmed | The role of annexin A1 in the modulation of the NLRP3 inflammasome. | 4.32e-05 | 4 | 94 | 2 | 32107769 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 15611103 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 25413331 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 34595678 | ||
| Pubmed | Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. | 4.32e-05 | 4 | 94 | 2 | 25075770 | |
| Pubmed | The mitochondrial respiratory chain is essential for haematopoietic stem cell function. | 4.32e-05 | 4 | 94 | 2 | 28504706 | |
| Pubmed | Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells. | 4.32e-05 | 4 | 94 | 2 | 24965773 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 21278747 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 4.32e-05 | 4 | 94 | 2 | 11104663 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 16157329 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPG ADAM15 PI4KA POLE MTR SLC35B2 PUM1 ESPL1 STAG2 PCK2 NUP205 | 4.84e-05 | 942 | 94 | 11 | 31073040 |
| Pubmed | 5.99e-05 | 152 | 94 | 5 | 34299191 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 19897194 | ||
| Pubmed | TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. | 7.19e-05 | 5 | 94 | 2 | 29715200 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 37573690 | ||
| Pubmed | Mitochondrial complex III is essential for suppressive function of regulatory T cells. | 7.19e-05 | 5 | 94 | 2 | 30626970 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 19838218 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 39039288 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 33658352 | ||
| Pubmed | Endothelial Cyp26b1 restrains murine heart valve growth during development. | 8.34e-05 | 163 | 94 | 5 | 35364055 | |
| Pubmed | 8.96e-05 | 32 | 94 | 3 | 31815296 | ||
| Pubmed | 9.38e-05 | 87 | 94 | 4 | 33798452 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 19349279 | ||
| Pubmed | Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. | 1.08e-04 | 6 | 94 | 2 | 14676841 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 1.18e-04 | 35 | 94 | 3 | 21252157 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCAPG GTF3C1 TRIO POLDIP3 PI4KA POLE MTR DDX56 NOL9 TDRD6 PUM1 STAG2 NUP205 | 1.19e-04 | 1425 | 94 | 13 | 30948266 |
| Pubmed | Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3. | 1.50e-04 | 7 | 94 | 2 | 14516789 | |
| Pubmed | Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand. | 1.50e-04 | 7 | 94 | 2 | 16099422 | |
| Pubmed | Editing activity for eliminating mischarged tRNAs is essential in mammalian mitochondria. | 1.50e-04 | 7 | 94 | 2 | 29228266 | |
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 10930463 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 14982882 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GTF3C1 MCPH1 TRIO RTEL1 RIN2 OSBPL5 BARD1 ZFHX2 LRP5 DDX56 STAG2 DNAH14 NOTCH3 | 1.84e-04 | 1489 | 94 | 13 | 28611215 |
| Pubmed | 1.89e-04 | 41 | 94 | 3 | 8724849 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 27339457 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 8918464 | ||
| Pubmed | Tex19 paralogs are new members of the piRNA pathway controlling retrotransposon suppression. | 2.00e-04 | 8 | 94 | 2 | 28254886 | |
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 19584108 | ||
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 23585563 | ||
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 24663677 | ||
| Pubmed | IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. | 3.91e-04 | 11 | 94 | 2 | 23935505 | |
| Pubmed | 3.99e-04 | 653 | 94 | 8 | 22586326 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MST1R ITGA11 GTF3C1 FSTL3 ADAM15 LRP5 SLC35B2 LTBP1 LTBP3 ITGA5 NOTCH3 | 4.00e-04 | 1201 | 94 | 11 | 35696571 |
| Pubmed | NODs: intracellular proteins involved in inflammation and apoptosis. | 4.69e-04 | 12 | 94 | 2 | 12766759 | |
| Pubmed | 5.53e-04 | 13 | 94 | 2 | 17376863 | ||
| Pubmed | 5.79e-04 | 140 | 94 | 4 | 16778019 | ||
| Pubmed | 6.44e-04 | 14 | 94 | 2 | 18561907 | ||
| Pubmed | 6.44e-04 | 14 | 94 | 2 | 18393306 | ||
| Pubmed | 6.44e-04 | 14 | 94 | 2 | 20403135 | ||
| Pubmed | 6.44e-04 | 14 | 94 | 2 | 12563287 | ||
| Pubmed | Notch signaling differentially regulates Atoh7 and Neurog2 in the distal mouse retina. | 6.44e-04 | 14 | 94 | 2 | 25100656 | |
| Pubmed | 7.42e-04 | 15 | 94 | 2 | 17804598 | ||
| Pubmed | 7.42e-04 | 15 | 94 | 2 | 16120479 | ||
| Pubmed | CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1. | 7.42e-04 | 15 | 94 | 2 | 35487060 | |
| Pubmed | The RNA helicase MOV10L1 binds piRNA precursors to initiate piRNA processing. | 7.42e-04 | 15 | 94 | 2 | 25762440 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 7.50e-04 | 150 | 94 | 4 | 30154076 | |
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 25577283 | ||
| Pubmed | 8.49e-04 | 733 | 94 | 8 | 34672954 | ||
| Pubmed | 9.57e-04 | 17 | 94 | 2 | 19345099 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.06e-03 | 759 | 94 | 8 | 35915203 | |
| Pubmed | 1.06e-03 | 284 | 94 | 5 | 29459677 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCAPG GTF3C1 POLDIP3 PI4KA POLE KIF21A DDX56 NOL9 PUM1 PCK2 NUP205 | 1.07e-03 | 1353 | 94 | 11 | 29467282 |
| Pubmed | 1.08e-03 | 18 | 94 | 2 | 10842103 | ||
| Pubmed | 1.08e-03 | 18 | 94 | 2 | 26446231 | ||
| Pubmed | Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly. | 1.33e-03 | 20 | 94 | 2 | 32294449 | |
| Pubmed | 1.33e-03 | 20 | 94 | 2 | 19605690 | ||
| Pubmed | Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. | 1.36e-03 | 176 | 94 | 4 | 18614564 | |
| Pubmed | 1.39e-03 | 613 | 94 | 7 | 22268729 | ||
| Pubmed | 1.47e-03 | 21 | 94 | 2 | 20708005 | ||
| Pubmed | 1.47e-03 | 21 | 94 | 2 | 25590999 | ||
| Pubmed | 1.61e-03 | 22 | 94 | 2 | 36877136 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.91e-03 | 1031 | 94 | 9 | 16710414 | |
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 1.92e-03 | 24 | 94 | 2 | 26552887 | |
| Pubmed | 1.98e-03 | 481 | 94 | 6 | 28190767 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.05e-03 | 197 | 94 | 4 | 20811636 | |
| Pubmed | Gse1, a component of the CoREST complex, is required for placenta development in the mouse. | 2.08e-03 | 25 | 94 | 2 | 37019373 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 2.08e-03 | 331 | 94 | 5 | 19490893 | |
| Pubmed | 2.11e-03 | 332 | 94 | 5 | 25693804 | ||
| Pubmed | 2.15e-03 | 1049 | 94 | 9 | 27880917 | ||
| Interaction | TOP3B interactions | VWA5B2 MST1R TRAF4 TRIO RTEL1 POLDIP3 PI4KA POLE OSBPL5 SHC1 LRP5 DDX56 HMGXB3 LTBP3 FBXL19 ITGA5 PUM1 ESPL1 ULK2 TTC38 PLEKHH3 | 1.80e-06 | 1470 | 91 | 21 | int:TOP3B |
| GeneFamily | Latent transforming growth factor beta binding proteins | 9.34e-05 | 4 | 72 | 2 | 628 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-05 | 258 | 91 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.32e-05 | 48 | 91 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-06 | 159 | 94 | 6 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 171 | 94 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.29e-06 | 180 | 94 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 189 | 94 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 191 | 94 | 6 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.23e-06 | 191 | 94 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-06 | 197 | 94 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.97e-06 | 198 | 94 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-06 | 199 | 94 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 146 | 94 | 5 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.56e-05 | 148 | 94 | 5 | c95a732163050cfb5d604c2a4c9eb1afa9f19a95 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.61e-05 | 149 | 94 | 5 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-05 | 164 | 94 | 5 | 84a1808bc6f501218ac2a5a05eb188a07ccd3890 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-05 | 167 | 94 | 5 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.87e-05 | 168 | 94 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 172 | 94 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.30e-05 | 173 | 94 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.30e-05 | 173 | 94 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 176 | 94 | 5 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 176 | 94 | 5 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.68e-05 | 177 | 94 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-05 | 177 | 94 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-05 | 177 | 94 | 5 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.89e-05 | 179 | 94 | 5 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 180 | 94 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.10e-05 | 181 | 94 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-05 | 181 | 94 | 5 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 182 | 94 | 5 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-05 | 183 | 94 | 5 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.43e-05 | 184 | 94 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 185 | 94 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 94 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-05 | 188 | 94 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 188 | 94 | 5 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.91e-05 | 188 | 94 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.91e-05 | 188 | 94 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 188 | 94 | 5 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-05 | 188 | 94 | 5 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 189 | 94 | 5 | 562f8bf5a7d38afb4a8f2415d617d5f79cfb7e3f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 189 | 94 | 5 | 270dd4a0fc5260288fe6829837942c78b40ecec4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 190 | 94 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 190 | 94 | 5 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 191 | 94 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.42e-05 | 192 | 94 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 192 | 94 | 5 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.42e-05 | 192 | 94 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 192 | 94 | 5 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 192 | 94 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 193 | 94 | 5 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.56e-05 | 193 | 94 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.56e-05 | 193 | 94 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.56e-05 | 193 | 94 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 193 | 94 | 5 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.56e-05 | 193 | 94 | 5 | 00c9c2945d2bdaa128e054cf3c59df86a279b659 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 194 | 94 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-05 | 194 | 94 | 5 | 935ec4554d740935d9d9a59d9d6b5293d1c27d1f | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.83e-05 | 195 | 94 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.83e-05 | 195 | 94 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.98e-05 | 196 | 94 | 5 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.98e-05 | 196 | 94 | 5 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.98e-05 | 196 | 94 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 197 | 94 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.12e-05 | 197 | 94 | 5 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.12e-05 | 197 | 94 | 5 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-05 | 198 | 94 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.27e-05 | 198 | 94 | 5 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.42e-05 | 199 | 94 | 5 | d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.58e-05 | 200 | 94 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.58e-05 | 200 | 94 | 5 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 123 | 94 | 4 | 3b97ff4de1e16652291db1c9e2a8474675fcdbfe | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 123 | 94 | 4 | fd981879529ced0e3023a1f3f8794ce8ff4d99a8 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.61e-04 | 129 | 94 | 4 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 130 | 94 | 4 | 1720f16ac06951c3f57b6c3b0944670a571203d1 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 131 | 94 | 4 | aeeb5718b3a7122492ad2659d5c8112f60839ff3 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-04 | 53 | 94 | 3 | d55030028f9ac970afb343ef6e1c41ab4bb2ae53 | |
| Disease | lower face morphology measurement | 3.38e-04 | 109 | 89 | 4 | EFO_0010948 | |
| Disease | blood nickel measurement | 4.87e-04 | 120 | 89 | 4 | EFO_0007583 | |
| Disease | Dental enamel hypoplasia | 5.82e-04 | 12 | 89 | 2 | EFO_1001304 | |
| Disease | age at last pregnancy measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0009440 | |
| Disease | medial orbital frontal cortex volume measurement | 2.58e-03 | 25 | 89 | 2 | EFO_0010315 | |
| Disease | Squamous cell carcinoma of esophagus | 3.01e-03 | 95 | 89 | 3 | C0279626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCIGVSQGACAEHLP | 26 | A8MUN3 | |
| ILREPVCLGGCEHIF | 56 | Q99728 | |
| RCLAGHCGIPELIVN | 2811 | Q7Z407 | |
| GPGLVCIDHRCQRVD | 636 | Q13444 | |
| HLCRGPGTLECAELL | 186 | Q8WXI3 | |
| LGALICIECSGIHRN | 961 | Q99490 | |
| VLPHTAVCLLCGEAG | 81 | Q6PCT2 | |
| LVLATVPLLGAACCH | 601 | Q6UXK2 | |
| CLQGLLENSPHLICI | 571 | Q9Y620 | |
| AGRVVHICNLPEGSC | 516 | Q5T481 | |
| RCQEGCGLPLTHGEQ | 141 | Q9UPQ7 | |
| HQLRCNGVLEGIRIC | 691 | P12883 | |
| QDPGVLGCPRTCLHA | 1021 | Q92621 | |
| LGCPRTCLHAILNIL | 1026 | Q92621 | |
| LCIGAVPGLQPRCHR | 1551 | Q96PE2 | |
| VHCQEPRRQLAGGPC | 706 | Q6GQQ9 | |
| CEHRGLAGLACAPIK | 181 | Q8NGH9 | |
| NCLLVGAIAIPHCVL | 636 | Q5SY16 | |
| GAIAIPHCVLKCQRG | 641 | Q5SY16 | |
| PHCVLKCQRGIEGTV | 646 | Q5SY16 | |
| PVAKLCELVHLCGGR | 771 | Q8NEM0 | |
| CELVHLCGGRVSQVP | 776 | Q8NEM0 | |
| IGFIALDRCICVLHP | 116 | P25090 | |
| LQEVGLHGNPIRCDC | 361 | O75325 | |
| ILHSGGCPCEGTLRL | 331 | Q9NR63 | |
| LPCHRLQVGDVCISI | 566 | P0C7T5 | |
| HATRCGCPIGLELLS | 621 | O75197 | |
| CIRHKGTVVLCPQTG | 261 | Q9NRM6 | |
| CVLNGELPLRSRCHI | 286 | Q9NY93 | |
| LQHLLRQCGIPFGAE | 1011 | Q12766 | |
| LPGELCQHLCINTVG | 611 | P98095 | |
| SARLCQPEGIHICDG | 51 | Q16822 | |
| RGCSEGHCLVTPEIQ | 4026 | Q9NYQ8 | |
| PDICGAGHCINLPVR | 881 | Q14766 | |
| SIGANPCEHLGRCVN | 396 | Q9UM47 | |
| IAHLPLLICCLQGLG | 476 | P42356 | |
| CQAHGEPVLGLCPLL | 81 | Q86UT5 | |
| VPLLFRALVHLGCVC | 1431 | Q07864 | |
| CPVIHGNCTKLNLGR | 76 | Q9UKX5 | |
| QLCGHITHRGPCVAV | 281 | Q6P9B6 | |
| LPLCGHRRVEGFLCE | 166 | O95371 | |
| EVGLRPHQVEVVCCL | 96 | P0C024 | |
| GCRVIQRILEHCLPD | 1006 | Q14671 | |
| CFRLRCELGPLHQQE | 916 | P08648 | |
| ACAISEPLCQHLGLV | 476 | Q14674 | |
| KNCLEILCRHGGLEP | 926 | Q8WZ74 | |
| INLLGFLGLVHCLPC | 81 | O95633 | |
| ALLGRHCPLCVPAGE | 86 | J3KSC0 | |
| CGGQLFIIPCSRVGH | 346 | Q7Z4T8 | |
| CRLGHCPDPVLVNGE | 76 | P20851 | |
| EPGVVGLCCAVLPIH | 131 | Q0VDD8 | |
| LCPQGHRLVGGRKCQ | 851 | Q9NS15 | |
| CAGRVPALLLCLGFH | 11 | O14944 | |
| DGNICRHLLPRVQCP | 221 | Q86WA6 | |
| VHIQDVGGLICRACN | 71 | Q5W0N0 | |
| CLQCDPLVLEALGHL | 21 | Q6UXV1 | |
| ELRCVCLQTTQGVHP | 46 | P42830 | |
| CVCGALKRARLVHPG | 301 | Q9BY77 | |
| VGTVLLHCCELIERP | 166 | Q9H0X9 | |
| VDGCIHRAAGPCLLA | 101 | A1Z1Q3 | |
| LCETLQHPGCNIRRL | 761 | Q96P20 | |
| IQLCGMGILPEHCII | 481 | Q9NQT8 | |
| CVLGSREQLCIHPEV | 136 | Q9NZ71 | |
| YLLVGLSRLQCGHCP | 46 | Q14D33 | |
| KLGVTGLRCNQCEPH | 871 | O75445 | |
| VCEVLSCDHNGGLPR | 141 | Q9BZX4 | |
| RQELLCTVHCPGAGA | 401 | Q7Z736 | |
| LVNAILPGLCIHCSL | 1406 | O60522 | |
| LPGLCIHCSLQGFEV | 1411 | O60522 | |
| GRVVLAAHECLLCAP | 266 | A6NFQ2 | |
| LRGVCLQQPHLCLVL | 186 | Q5TCX8 | |
| LRNFHLPCGQERGCL | 116 | Q9BWX1 | |
| VRQGCGIPTHYVCVL | 896 | Q8TC59 | |
| LSRRIAGGEEACPHC | 571 | Q7RTY7 | |
| LQCLVLICEAIPHPG | 216 | Q9Y2N7 | |
| LSGLQGLPECTRCGH | 246 | P50479 | |
| ISVSHGEPLCIGLNC | 246 | Q99707 | |
| PLLCLCVVAAHLAGA | 6 | Q8IUL8 | |
| IHPVVRNLAVLCLGC | 596 | Q9BPX3 | |
| CPASLRQLCLINGVH | 236 | Q8WYP3 | |
| VILIGVCTHLGCVPI | 211 | P47985 | |
| CPLCQEQLVGRPALH | 1011 | Q9C0A1 | |
| CLPVCCNRVLGIHHI | 311 | P18577 | |
| VAGLSCVLCKQPRHG | 166 | Q8TB61 | |
| LCTIRQAAECHPPVG | 526 | Q8N3U4 | |
| GIRAFPLQCIHIAEG | 1331 | Q7Z4S6 | |
| CVAVHCVAGLGRAPV | 96 | Q12974 | |
| PGSLVKHICAICGDR | 131 | P48443 | |
| VLGLPIRCIHSEEGC | 76 | Q9BUZ4 | |
| RLHTGERPNLCADCG | 281 | Q5TEC3 | |
| GNEPRECAHCLLVQG | 636 | Q8IYT8 | |
| NCQHLLARDVGLPLC | 366 | Q5R3I4 | |
| APRCHVVIRGLCGEQ | 836 | Q8N398 | |
| ILIGVCTHLGCVPIA | 221 | P0C7P4 | |
| LAVLLPGRHPCDCLG | 161 | Q15650 | |
| VSLRLQEIHPECGPC | 306 | Q12789 | |
| LQVCVDGECHILGRV | 931 | Q04912 | |
| PVNQRACHILECPEG | 281 | P29353 | |
| AAEGLVPCGSLCIAH | 1706 | O75962 | |
| LHCRASGVGVCQLPG | 1921 | Q9Y493 | |
| DGVQLLCEALRHPKC | 801 | Q86W24 |